INmune Bio, Inc. (INMB) vs NOMAD Power Solutions, Inc. (NMAD)
A side-by-side comparison of INmune Bio, Inc. and NOMAD Power Solutions, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
INMB
INmune Bio, Inc.
$1.90HealthcareDelayed quote: Oct 6, 2026, 12:39 PM EDT
NMAD
NOMAD Power Solutions, Inc.
$4.20HealthcareDelayed quote: Oct 6, 2026, 12:38 PM EDT
Total return — INMB vs NMAD
growth of $100 · dividends reinvested · last 1yINMB +54.0% (+54.0%/yr)NMAD -39.7% (-39.7%/yr)INMB compounded faster over this window
INMB NMAD
INMB vs NMAD: by the numbers
- •NMAD is the larger company ($52M vs $51M market cap).
- •Both run net losses; NMAD's is the smaller (0.00% vs -91866.00% net margin).
Metrics side by side
Valuation
| Metric | INMB | NMAD |
|---|---|---|
| P/B ratio | 2.48 | 2171.03 |
Profitability
| Metric | INMB | NMAD |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -61738.00% | 0.00% |
| Net margin | -91866.00% | 0.00% |
| ROE | -90.44% | -36114.03% |
| ROIC | -96.37% | -31665.34% |
Growth (annualized)
| Metric | INMB | NMAD |
|---|---|---|
| Total return CAGR (5Y) | -36.88% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.